Synopsis
Synopsis
0
JDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 14919-77-8
2. Benserazide Hcl
3. 2-amino-3-hydroxy-n'-(2,3,4-trihydroxybenzyl)propanehydrazide Hydrochloride
4. Benzerazide Hydrochloride
5. Benserazide (hydrochloride)
6. 2'-(2,3,4-trihydroxybenzyl)-dl-serinohydrazide Monohydrochloride
7. Ro 4-4602/001
8. Benserazide Hydrochloride [jan]
9. 14046-64-1
10. Dl-serine 2-(2,3,4-trihydroxybenzyl)hydrazine Hydrochloride
11. 2-amino-3-hydroxy-n'-[(2,3,4-trihydroxyphenyl)methyl]propanehydrazide Hydrochloride
12. Mls000028424
13. B66e5rk36q
14. Dl-serine 2-(2,3,4-trihydroxybenzyl)hydrazide Hydrochloride
15. Chebi:31262
16. (s)-2-amino-3-hydroxy-n'-(2,3,4-trihydroxybenzyl)propanehydrazide Hydrochloride
17. 2-amino-3-hydroxy-n'-[(2,3,4-trihydroxyphenyl)methyl]propanehydrazide;hydrochloride
18. Nsc-755907
19. Smr000058421
20. Ro-4-4602
21. Dsstox_cid_25412
22. Dsstox_rid_80862
23. Dsstox_gsid_45412
24. Benserazide (as Hydrochloride)
25. 3-hydroxy-1-oxo-1-[2-(2,3,4-trihydroxybenzyl)hydrazinyl]propan-2-aminium Chloride
26. Ccris 5092
27. Sr-01000003044
28. Einecs 238-991-9
29. Unii-b66e5rk36q
30. Mfcd00078571
31. Opera_id_1594
32. Ncgc00016709-01
33. Madopa (hoffmann-laroche)
34. Cas-14919-77-8
35. Mls001148252
36. Mls002222160
37. Schembl364720
38. Spectrum1500137
39. Chembl1255778
40. Dtxsid0045412
41. Hy-b0404a
42. Benserazide Hydrochloride (jp17)
43. Benserazide Hydrochloride - Bio-x
44. Hms1570l18
45. Hms1920g05
46. Pharmakon1600-01500137
47. Bcp14068
48. Cba17287
49. Tox21_110573
50. Tox21_500233
51. Ccg-38998
52. Nsc755907
53. S2453
54. Serine, 2-(2,3,4-trihydroxybenzyl)hydrazide, Monohydrochloride, Dl-
55. Benserazide Hydrochloride [mi]
56. Akos007930267
57. Dl-serine, 2-((2,3,4-trihydroxyphenyl)methyl)hydrazide, Monohydrochloride
58. Tox21_110573_1
59. Ac-6825
60. H22b350
61. Lp00233
62. Nsc 755907
63. Sb44383
64. Benserazide Middot Hcl (ro 4-4602)
65. Benserazide Hydrochloride [mart.]
66. Ncgc00015163-09
67. Ncgc00093698-01
68. Ncgc00093698-02
69. Ncgc00093698-03
70. Ncgc00093698-04
71. Ncgc00093698-05
72. Ncgc00260918-01
73. As-13683
74. Bb166155
75. Benserazide Hydrochloride [who-dd]
76. B4108
77. Eu-0100233
78. Ft-0659734
79. Ft-0760799
80. Sw196391-3
81. B 7283
82. Benserazide Hydrochloride [ep Monograph]
83. D01653
84. D70746
85. Benserazide Hydrochloride, >=98% (tlc), Solid
86. A808862
87. Sr-01000003044-2
88. Sr-01000003044-8
89. W-108090
90. Q27114249
91. 2-amino-3-hydroxy-n'-(2,3,4-trihydroxybenzyl)propanehydrazidehydrochloride
92. Benserazide Hydrochloride, European Pharmacopoeia (ep) Reference Standard
93. Dl-serine, 2-[(2,3,4-trihydroxyphenyl)methyl]hydrazide Hydrochloride
94. Serine, 2-[(2,3,4-trihydroxyphenyl)methyl]hydrazide, Hydrochloride (1:1)
95. 2-amino-3-hydroxy-n'-(2,3,4-trihydroxybenzyl)-propanehydrazide Hydrochloride
96. Benserazide For Peak Identification, European Pharmacopoeia (ep) Reference Standard
97. 2-amino-3-hydroxy-n'-(2,3,4-trihydroxybenzyl)-propanehydrazide Hydrochloride;benserazide Hcl
Molecular Weight | 293.70 g/mol |
---|---|
Molecular Formula | C10H16ClN3O5 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 5 |
Exact Mass | 293.0778483 g/mol |
Monoisotopic Mass | 293.0778483 g/mol |
Topological Polar Surface Area | 148 Ų |
Heavy Atom Count | 19 |
Formal Charge | 0 |
Complexity | 278 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
97
PharmaCompass offers a list of Benserazide Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Benserazide Hydrochloride manufacturer or Benserazide Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Benserazide Hydrochloride manufacturer or Benserazide Hydrochloride supplier.
PharmaCompass also assists you with knowing the Benserazide Hydrochloride API Price utilized in the formulation of products. Benserazide Hydrochloride API Price is not always fixed or binding as the Benserazide Hydrochloride Price is obtained through a variety of data sources. The Benserazide Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Benzerazide Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Benzerazide Hydrochloride, including repackagers and relabelers. The FDA regulates Benzerazide Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Benzerazide Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Benzerazide Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Benzerazide Hydrochloride supplier is an individual or a company that provides Benzerazide Hydrochloride active pharmaceutical ingredient (API) or Benzerazide Hydrochloride finished formulations upon request. The Benzerazide Hydrochloride suppliers may include Benzerazide Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Benzerazide Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Benzerazide Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Benzerazide Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Benzerazide Hydrochloride DMFs exist exist since differing nations have different regulations, such as Benzerazide Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Benzerazide Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Benzerazide Hydrochloride USDMF includes data on Benzerazide Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Benzerazide Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Benzerazide Hydrochloride suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Benzerazide Hydrochloride Drug Master File in Korea (Benzerazide Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Benzerazide Hydrochloride. The MFDS reviews the Benzerazide Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Benzerazide Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Benzerazide Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Benzerazide Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Benzerazide Hydrochloride suppliers with KDMF on PharmaCompass.
A Benzerazide Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Benzerazide Hydrochloride Certificate of Suitability (COS). The purpose of a Benzerazide Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Benzerazide Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Benzerazide Hydrochloride to their clients by showing that a Benzerazide Hydrochloride CEP has been issued for it. The manufacturer submits a Benzerazide Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Benzerazide Hydrochloride CEP holder for the record. Additionally, the data presented in the Benzerazide Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Benzerazide Hydrochloride DMF.
A Benzerazide Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Benzerazide Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Benzerazide Hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Benzerazide Hydrochloride written confirmation (Benzerazide Hydrochloride WC) is an official document issued by a regulatory agency to a Benzerazide Hydrochloride manufacturer, verifying that the manufacturing facility of a Benzerazide Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Benzerazide Hydrochloride APIs or Benzerazide Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Benzerazide Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Benzerazide Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
Benzerazide Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Benzerazide Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Benzerazide Hydrochloride GMP manufacturer or Benzerazide Hydrochloride GMP API supplier for your needs.
A Benzerazide Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Benzerazide Hydrochloride's compliance with Benzerazide Hydrochloride specifications and serves as a tool for batch-level quality control.
Benzerazide Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Benzerazide Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Benzerazide Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Benzerazide Hydrochloride EP), Benzerazide Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Benzerazide Hydrochloride USP).